Establishes "New Jersey Menopause Coverage Act"; requires health insurance coverage of medically necessary perimenopause and menopause treatments.
Impact
If enacted, A5278 will amend existing statutory provisions to ensure that health insurance policies in New Jersey must cover a wide array of treatments associated with menopause. This bill seeks to provide clarity in coverage and enhance accessibility to necessary healthcare services that could lead to improved health outcomes for women experiencing symptoms of menopause. By mandating coverage for treatments such as bone health medications and counseling, the bill advances women’s health needs within the state and encourages health service corporations to be more inclusive in their benefit offerings.
Summary
Assembly Bill A5278, known as the 'New Jersey Menopause Coverage Act', aims to expand health insurance coverage for medically necessary treatments related to perimenopause and menopause. The bill requires that health service corporation contracts provide comprehensive benefits for women diagnosed with perimenopause and menopause. This includes a variety of treatment options such as hormonal therapies, non-hormonal treatments for managing symptoms, behavioral health care services, physical therapy, and preventive services recommended by the United States Preventive Services Task Force. The intent of the legislation is to address a critical gap in healthcare for women undergoing this natural life stage.
Sentiment
The legislative sentiment around A5278 has been largely supportive, particularly among women's health advocates and healthcare professionals who recognize the importance of addressing menopause-related health issues. Supporters argue that this bill will alleviate the financial burden on women who often face significant out-of-pocket expenses for necessary treatments. However, some concerns have been raised regarding the potential impacts on insurance premiums and the economy of health service providers adapting to the new coverage requirements.
Contention
Notable points of contention surrounding A5278 include the debate over healthcare costs and the implications for insurance providers in meeting the increased coverage requirements. Critics may argue that mandating additional coverage could drive up premiums, potentially making insurance less affordable for some individuals. Proponents counter that improved health outcomes for women and preventive care measures could ultimately lower long-term healthcare costs, presenting a compelling case for the bill's passage.
Same As
Establishes "New Jersey Menopause Coverage Act"; requires health insurance coverage of medically necessary perimenopause and menopause treatments.
Insurance: health insurers; coverage for treatment of menopause and perimenopause symptoms and waiver of prior authorization for prescription drugs or treatments for menopause and perimenopause symptoms; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406zz.
Insurance: health insurers; coverage for treatment of menopause and perimenopause symptoms and waiver of prior authorization for prescription drugs or treatments for menopause and perimenopause symptoms; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406zz.
Designates October of each year as "Menopause Awareness Month" October 11 of each year as "Perimenopause Day," and October 18 of each year as "Postmenopause Day" in New Jersey.
Designates October of each year as "Menopause Awareness Month," October 11 of each year as "Perimenopause Day," and October 18 of each year as "Postmenopause Day" in New Jersey.
Establishes interagency council on menopause in DOH and requires certain lincensed health care professionals to distribute menopause informational pamphlets under certain circumstances.